Advanced search
Publication Cover
Acta Oncologica Volume 48, 2009 - Issue 4
Journal homepage
2,781
Views
123
CrossRef citations to date
0
Altmetric
Original Article

Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis

Kyle E. Rusthoven Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Colorado, Denver, USACorrespondence[email protected]
,
Susan F. Hammerman Department of Medical Oncology, University of Colorado Comprehensive Cancer Center, Colorado, Denver, USA
,
Brian D. Kavanagh Department of Radiation Oncology, University of Colorado Comprehensive Cancer Center, Colorado, Denver, USA
,
Michael J. Birtwhistle Department of Medical Oncology, University of Colorado Comprehensive Cancer Center, Colorado, Denver, USA
,
Mark Stares Department of Medical Oncology, University of Colorado Comprehensive Cancer Center, Colorado, Denver, USA
&
D. Ross Camidge Department of Medical Oncology, University of Colorado Comprehensive Cancer Center, Colorado, Denver, USA
Pages 578-583 | Received 05 Jun 2008, Published online: 08 Jul 2009

Citations (123)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Huiqin Li & Bing Lu. (2022) Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment. Cancer Management and Research 14, pages 3347-3358.
Read now
Cole R. Steber, Ryan T. Hughes, Michael H. Soike, Corbin A. Helis, Karina Nieto, Travis Jacobson, Moeko Nagatsuka, Hamilton S. McGinnis, C. Marc Leyrer & Michael K. Farris. (2021) Stereotactic body radiotherapy for synchronous early stage non-small cell lung cancer. Acta Oncologica 60:5, pages 605-612.
Read now
Patrick J Richard & Ramesh Rengan. (2016) Oligometastatic non-small-cell lung cancer: current treatment strategies. Lung Cancer: Targets and Therapy 7, pages 129-140.
Read now
Derek P. Bergsma, Joseph K Salama, Deepinder P. Singh, Steven J Chmura & Michael T. Milano. (2015) The evolving role of radiotherapy in treatment of oligometastatic NSCLC. Expert Review of Anticancer Therapy 15:12, pages 1459-1471.
Read now
Esben S. Worm, Anders T. Hansen, Jørgen B. Petersen, Ludvig P. Muren, Lars H. Præstegaard & Morten Høyer. (2010) Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung. Acta Oncologica 49:7, pages 1177-1183.
Read now

Articles from other publishers (118)

Cole Friedes, Nikhil Yegya-Raman, Siqi Zhang, Michelle Iocolano, Roger B. Cohen, Charu Aggarwal, Jeffrey C. Thompson, Melina E. Marmarelis, William P. Levin, Keith A. Cengel, Christine A. Ciunci, Aditi P. Singh, Christopher D'Avella, Christiana W. Davis, Corey J. Langer & Steven J. Feigenberg. (2023) Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression. Clinical Lung Cancer.
Crossref
Yahan Huang, Yongmei Kong, Zhigang Wei & Xin Ye. (2022) Image‐guided thermal ablation for patients with epidermal growth factor receptor‐mutant nonsmall cell lung cancer. Asia-Pacific Journal of Clinical Oncology 19:4, pages 427-433.
Crossref
Rongxin Liao, Kehong Chen, Jinjin Li, Hengqiu He, Guangming Yi, Mingfeng Huang, Rongrong Chen, Lu Shen, Xiaoyue Zhang, Zaicheng Xu, Zhenzhou Yang & Yuan Peng. (2023) Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non–Small Cell Lung Cancer. Cancer Research and Treatment 55:3, pages 814-831.
Crossref
Andrew Tam, Nicholas Eustace, Ari Kassardjian, Howard West, Terence M. Williams & Arya Amini. (2023) The Emerging Role of Radiotherapy in Oligoprogressive Non-Small Cell Lung Cancer. Surgical Oncology Clinics of North America 32:3, pages 497-514.
Crossref
Jie Zhao, Haiming Liu, Tao Qi, Hui Zhao, Tingting Ye & Peng Ning. (2023) Efficacy and safety analysis of stereotactic body radiotherapy for brain multi-metastases in non-small cell lung cancer patients. Technology and Health Care, pages 1-9.
Crossref
Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Huiqin Li & Bing Lu. (2023) Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy. Frontiers in Oncology 13.
Crossref
Jacob Langston, Tejas Patil, D. Ross Camidge, Paul A. Bunn, Erin L. Schenk, Jose M. Pacheco, James Jurica, Timothy V. Waxweiler, Brian D. Kavanagh & Chad G. Rusthoven. (2023) CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer. Lung Cancer 178, pages 103-107.
Crossref
润莎 刘. (2023) Progress of Clinical Research on Systemic Combined Local Treatment for Oligometastatic NSCLC. Advances in Clinical Medicine 13:09, pages 13863-13873.
Crossref
Ying-Yuan Chen, Po-Lan Su, Wei-Li Huang, Chao-Chun Chang, Yi-Ting Yen, Chien-Chung Lin & Yau-Lin Tseng. (2022) The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort study. Scientific Reports 12:1.
Crossref
Antonio José Conde-Moreno, Aránzazu González-del-Alba, Fernando López-Campos, Carlos López López, Ovidio Hernando Requejo, Javier de Castro Carpeño, Rodolfo Chicas-Sett, Laura de Paz Arias, Ángel Montero-Luis, Aurora Rodríguez Pérez, Enriqueta Felip Font & José Ángel Arranz Arija. (2022) Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer. Clinical and Translational Oncology 25:4, pages 897-911.
Crossref
Aurora Rodríguez Pérez, Enriqueta Felip Font, Rodolfo Chicas-Sett, Ángel Montero-Luis, Laura de Paz Arias, Aránzazu González-del-Alba, Fernando López-Campos, Carlos López López, Ovidio Hernando Requejo, Antonio José Conde-Moreno, José Ángel Arranz Arija & Javier de Castro Carpeño. (2022) Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part I: non-small cell lung cancer and breast cancer. Clinical and Translational Oncology 25:4, pages 882-896.
Crossref
Suli Zhang, Qian Sun, Feng Cai, Hui Li & Yufu Zhou. (2022) Local therapy treatment conditions for oligometastatic non-small cell lung cancer. Frontiers in Oncology 12.
Crossref
R. Ratnakumaran & F. McDonald. (2022) The Management of Oligometastases in Non-small Cell Lung Cancer – is Stereotactic Ablative Radiotherapy now Standard of Care?. Clinical Oncology 34:11, pages 753-760.
Crossref
Claudiu-Eduard Nistor, Adrian Ciuche, Anca Pati Cucu, Cornelia Nitipir, Cristina Slavu, Bogdan Serban, Adrian Cursaru, Bogdan Cretu & Catalin Cirstoiu. (2022) Management of Lung Cancer Presenting with Solitary Bone Metastasis. Medicina 58:10, pages 1463.
Crossref
P. Van Schil, L. Berzenji, A. Desmet & P. Van Houtte. (2022) Prise en charge des formes oligométastatiques : l’avis du chirurgien. Revue des Maladies Respiratoires Actualités 14:2, pages 2S146-2S150.
Crossref
Patricia Mae G. Santos, Xingzhe Li & Daniel R. Gomez. (2022) Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer. Cancers 14:16, pages 3977.
Crossref
Shuenn-Wen Kuo, Pei-Hsing Chen, Tzu-Pin Lu, Ke-Cheng Chen, Hsien-Chi Liao, Kuan-Chuan Tsou, Tung-Ming Tsai, Mong-Wei Lin, Hsao-Hsun Hsu & Jin-Shing Chen. (2022) Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case–Control Study. Annals of Surgical Oncology 29:8, pages 4873-4884.
Crossref
Jeongshim Lee, Woong Sub Koom, Hwa Kyung Byun, Gowoon Yang, Mi Sun Kim, Eun Jung Park, Joong Bae Ahn, Seung-Hoon Beom, Han Sang Kim, Sang Joon Shin, Kangpyo Kim & Jee Suk Chang. (2022) Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer. Clinical Colorectal Cancer 21:2, pages e78-e86.
Crossref
James M. Isbell, Bob T. Li & Daniel R. Gomez. (2022) The emerging role of local therapy in oligometastatic non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 163:3, pages 819-825.
Crossref
Rémy Kinj, Emilien Muggeo, Luis Schiappacasse, Jean Bourhis & Fernanda G. Herrera. (2022) Stereotactic Body Radiation Therapy in Patients with Oligometastatic Disease: Clinical State of the Art and Perspectives. Cancers 14:5, pages 1152.
Crossref
Katie Jasper, Brendon Stiles, Fiona McDonald & David A. Palma. (2022) Practical Management of Oligometastatic Non–Small-Cell Lung Cancer. Journal of Clinical Oncology 40:6, pages 635-641.
Crossref
Arya Amini, Vivek Verma, Charles B. SimoneIIII, Indrin J. Chetty, Stephen G. Chun, Jessica Donington, Martin J. Edelman, Kristin A. Higgins, Larry L. Kestin, Benjamin Movsas, George B. Rodrigues, Kenneth E. Rosenzweig, Igor I. Rybkin, Benjamin J. Slotman, Andrea Wolf & Joe Y. Chang. (2022) American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 112:2, pages 361-375.
Crossref
Q. A. Ho & C. C. Hsu. 2022. Cancer Metastasis Through the Lymphovascular System. Cancer Metastasis Through the Lymphovascular System 681 695 .
David L. Billing & Andreas Rimner. (2021) Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer. Cancers 13:22, pages 5773.
Crossref
Rong Chai, Yipengchen Yin, Xuwei Cai, Xiaolong Fu & Qin Zhang. (2021) Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Frontiers in Oncology 11.
Crossref
Xingzhe Li, Daniel Gomez & Puneeth Iyengar. (2021) Local Ablative Therapy in Oligometastatic NSCLC. Seminars in Radiation Oncology 31:3, pages 235-241.
Crossref
Diana M. Ghemiş & Loredana G. Marcu. (2021) Progress and prospects of flattening filter free beam technology in radiosurgery and stereotactic body radiotherapy. Critical Reviews in Oncology/Hematology 163, pages 103396.
Crossref
Martina Vrankar. 2021. Lung Cancer - Modern Multidisciplinary Management. Lung Cancer - Modern Multidisciplinary Management.
Mauro Loi, Marco Alifano, Marta Scorsetti, Joost J. Nuyttens & Lorenzo Livi. (2021) Judging a Fish by Its Ability to Climb a Tree? A Call for Novel Endpoints in the Appraisal of Ablative Local Treatments of Oligometastatic Cancer. The Oncologist 26:6, pages e1085-e1086.
Crossref
Feng-Ming (Spring) Kong, Vitali Moiseenko, Jing Zhao, Michael T. Milano, Ling Li, Andreas Rimner, Shiva Das, X. Allen Li, Moyed Miften, ZhongXing Liao, Mary Martel, Soren M. Bentzen, Andrew Jackson, Jimm Grimm, Lawrence B. Marks & Ellen Yorke. (2021) Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?. International Journal of Radiation Oncology*Biology*Physics 110:1, pages 172-187.
Crossref
Anil Tibdewal, Jai Prakash Agarwal, Shashank Srinivasan, Naveen Mummudi, Vanita Noronha, Kumar Prabhash, Vijay Patil, Nilendu Purandare, Amit Janu & Sadhna Kannan. (2021) Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1–5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial. BMJ Open 11:3, pages e043628.
Crossref
Anil Tibdewal, JaiPrakash Agarwal, Naveen Mummudi, Vanita Noronha, Kumar Prabhash, Vijay Patil, Nilendu Purandare, Amit Janu, Rajiv Kaushal & Sadhna Kannan. (2021) Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancer. BMJ Open 11:2, pages e041345.
Crossref
Jeng-Sen Tseng, Kuo-Hsuan Hsu, Zhe-Rong Zheng, Tsung-Ying Yang, Kun-Chieh Chen, Yen-Hsiang Huang, Kang-Yi Su, Sung-Liang Yu & Gee-Chen Chang. (2021) Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment. Oncology 99:1, pages 32-40.
Crossref
Taichi Miyawaki, Kazushige Wakuda, Hirotsugu Kenmotsu, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Akira Ono, Tateaki Naito, Haruyasu Murakami, Akifumi Notsu, Keita Mori, Hideyuki Harada, Masahiro Endo, Yasuhisa Ohde, Kazuhisa Takahashi & Toshiaki Takahashi. (2020) Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy. Cancer Science 112:1, pages 359-368.
Crossref
Yuqi Chen, Chengzhi Cai & Yanying Li. (2021) The impact of baseline brain metastases on clinical benefits and progression patterns after first-line crizotinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer. Medicine 100:8, pages e24784.
Crossref
Yusuke Kagawa, Hiromi Furuta, Takehiro Uemura, Naohiro Watanabe, Junichi Shimizu, Yoshitsugu Horio, Hiroaki Kuroda, Yoshitaka Inaba, Takeshi Kodaira, Katsuhiro Masago, Shiro Fujita, Akio Niimi & Toyoaki Hida. (2020) Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer. Cancer Science 111:12, pages 4442-4452.
Crossref
Christina G Attia, Naomi Fei, Mohammed Almubarak, Patrick C Ma & Malcolm D Mattes. (2020) Patterns of disease progression to checkpoint inhibitor immunotherapy in patients with stage IV non‐small cell lung cancer. Journal of Medical Imaging and Radiation Oncology 64:6, pages 866-872.
Crossref
Cole Friedes, Nicholas Mai, Sarah Hazell, Wei Fu, Peijin Han, Michael Bowers, Benjamin Levy, Patrick M. Forde, Ranh Voong & Russell K. Hales. (2020) Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram. Clinical Lung Cancer 21:6, pages e622-e632.
Crossref
Cole Friedes, Nicholas Mai, Wei Fu, Chen Hu, Sarah Z. Hazell, Peijin Han, Todd R. McNutt, Patrick M. Forde, Kristin J. Redmond, K. Ranh Voong & Russell K. Hales. (2020) Isolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapy. Cancer 126:20, pages 4572-4583.
Crossref
Vitali Moiseenko, Jimm Grimm, Ellen Yorke, Andrew Jackson, Anthony Yip, Minh-Phuong Huynh-Le, Anand Mahadevan, Kenneth Forster, Michael T Milano & Jona Hattangadi-Gluth. (2020) Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design. Cureus.
Crossref
P.-A. Laurent, E. Martin, J. Thariat & J. Doyen. (2020) Radiotherapy for primary tumor in lung cancer with synchronous metastases: Overview from the past and proposal for the future. Cancer/Radiothérapie 24:6-7, pages 554-558.
Crossref
Matthias Guckenberger, Kuno Lehmann & Isabelle Opitz. (2020) Oligometastasiertes nichtkleinzelliges Lungenkarzinom: lokaltherapeutische Optionen zur Behandlung von Lungen- und NebennierenmetastasenOligometastatic non-small-cell lung cancer: local treatment options for pulmonary and adrenal metastases. Der Onkologe 26:9, pages 800-815.
Crossref
Asal Rahimi & Robert Timmerman. (2020) Curing Metastatic Disease with Radiation Therapy: Myth or Reality?—Arguing for Reality. International Journal of Radiation Oncology*Biology*Physics 107:3, pages 429-432.
Crossref
Howard West. (2020) Management of Oligometastatic Disease in Advanced Non–Small Cell Lung Cancer. Clinics in Chest Medicine 41:2, pages 249-258.
Crossref
Tiantian Guo, Jianjiao Ni, Xi Yang, Yuan Li, Yida Li, Liqing Zou, Shengping Wang, Quan Liu, Li Chu, Xiao Chu, Shuyan Li, Luxi Ye & Zhengfei Zhu. (2020) Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 107:1, pages 62-71.
Crossref
Ying-Qiu Song, Nan Wang, Yun Qiao, Lei He, Xia Li, Xiao-Fang Zhang, Qian-Kun Yang, Run-Ze Wang, Rong He, Chen-Yu Wang, Yang-Wu Ren, Guang Li & Tian-Lu Wang. (2020) Treatment patterns and survival after 18F-fluorodeoxyglucose positron emission tomography/computed tomography-guided local consolidation therapy for oligometastatic non-small cell lung cancer: a two-center propensity score-matched analysis. Journal of Cancer Research and Clinical Oncology 146:4, pages 1021-1031.
Crossref
Michela Buglione, Barbara Alicja Jereczek-Fossa, Marco Lorenzo Bonù, Davide Franceschini, Andrei Fodor, Isa Bossi Zanetti, Marianna Alessandra Gerardi, Paolo Borghetti, Davide Tomasini, Nadia Gisella Di Muzio, Olga Oneta, Marta Scorsetti, Ciro Franzese, Paola Romanelli, Giampiero Catalano, Italo Dell'Oca, Giancarlo Beltramo, Giovanni Battista Ivaldi, Antonio Laudati, Stefano Maria Magrini & Paolo Antognoni. (2020) Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent. Lung Cancer 141, pages 1-8.
Crossref
May N. Tsao, Lieke in ’t Ven, Patrick Cheung, Ian Poon, Yee Ung & Alexander V. Louie. (2020) Stereotactic Body Radiation Therapy for Extracranial Oligometastatic Non–small-cell Lung Cancer: A Systematic Review. Clinical Lung Cancer 21:2, pages 95-105.e1.
Crossref
Wolfgang Schütte & Miriam Möller. (2020) Oligometastasiertes nicht kleinzelliges Lungenkarzinom: Vorteile einer lokalen Konsolidierungstherapie nutzen. Kompass Onkologie 7:1, pages 16-17.
Crossref
Jessica S. Donington. 2020. Difficult Decisions in Thoracic Surgery. Difficult Decisions in Thoracic Surgery 267 277 .
Jianjiao Ni, Guodong Li, Xi Yang, Li Chu, Jialei Wang, Yida Li, Liqing Zou, Yuan Li, Congying Xie & Zhengfei Zhu. (2019) Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses. Radiation Oncology 14:1.
Crossref
A.-M. Shiarli, F. McDonald & D.R. Gomez. (2019) When Should we Irradiate the Primary in Metastatic Lung Cancer?. Clinical Oncology 31:12, pages 815-823.
Crossref
Caryn Wujanto, Balamurugan Vellayappan, Shankar Siva, Alexander V. Louie, Matthias Guckenberger, Ben J. Slotman, Hiroshi Onishi, Yasushi Nagata, Mitchell Liu & Simon S. Lo. (2019) Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer. Frontiers in Oncology 9.
Crossref
Mathieu Spaas & Yolande Lievens. (2019) Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?. Frontiers in Medicine 6.
Crossref
Johannes Uhlig, Meaghan Dendy Case, Justin D. Blasberg, Daniel J. Boffa, Anne Chiang, Scott N. Gettinger & Hyun S. Kim. (2019) Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer. JAMA Network Open 2:8, pages e199702.
Crossref
BSH Chia, D Landau, G Hanna & J Conibear. (2018) Thoracic intervention and surgery to cure lung cancer: an overview of stereotactic ablative radiotherapy in early and oligometastatic lung cancer. Journal of the Royal Society of Medicine 112:8, pages 334-340.
Crossref
Nikhil Yegya-Raman, Joseph Aisner, Sinae Kim, Mutlay Sayan, Diana Li, John Langenfeld, Malini Patel, Jyoti Malhotra & Salma K. Jabbour. (2019) Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution. Advances in Radiation Oncology 4:3, pages 541-550.
Crossref
Paolo Borghetti, Marco Lorenzo Bonù, Rachele Giubbolini, Niccolo’ Giaj Levra, Rosario Mazzola, Marco Perna, Luca Visani, Fiammetta Meacci, Maria Taraborrelli, Luca Triggiani, Davide Franceschini, Carlo Greco, Alessio Bruni, Stefano Maria Magrini & Vieri Scotti. (2019) Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group. La radiologia medica 124:7, pages 662-670.
Crossref
P. Gustin, A. Botticella, L. Tselikas, O. Mercier, C. Le Péchoux & A. Levy. (2019) Prise en charge thérapeutique des cancers bronchiques non à petites cellules oligoprogressifs. Revue des Maladies Respiratoires 36:4, pages 519-526.
Crossref
Wolfgang Schütte & Miriam Möller. (2019) Oligometastasiertes nicht kleinzelliges Lungenkarzinom: Vorteile einer lokalen Konsolidierungstherapie nutzen. Kompass Pneumologie 7:6, pages 312-313.
Crossref
W. Jeffrey Petty, James J. Urbanic, Tamjeed Ahmed, Ryan Hughes, Beverly Levine, Kyle Rusthoven, Michael Papagikos, Jimmy R. Ruiz, Brian E. Lally, Michael Chan, Hollins Clark, Ralph B. D'AgostinoJr.Jr. & A. William Blackstock. (2018) Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 102:3, pages 527-535.
Crossref
Siobhra O’Sullivan & Daniel N. Cagney. (2018) The emerging role of stereotactic radiotherapy in gastrointestinal malignancies: a review of the literature and analysis from the Irish perspective. Irish Journal of Medical Science (1971 -) 187:4, pages 887-894.
Crossref
A. Desmet, P. Van Schil & P. Van Houtte. (2018) Quelles stratégies thérapeutiques pour les CBNPC oligo-métastatiques ?. Revue des Maladies Respiratoires Actualités 10:3, pages 326-331.
Crossref
Rui Zhang, Ping Li, Qin Li, Yunfeng Qiao, Tangpeng Xu, Peng Ruan, Qibin Song & Zhenming Fu. (2018) Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database. Cancer Medicine 7:10, pages 5015-5026.
Crossref
Ali Murat Sedef, Züleyha Çalıkuşu, Yasemin Bakkal Temi, Serkan Gökçay, Hüseyin Mertsoylu, Ali Ayberk Besen & Fatih Köse. (2018) Non-small-cell lung cancer (NSCLC) harboring driver mutation (EGFR mutation or ALK translocations) with clinical characteristics and management in a real-life setting: a retrospective observational multicenter case series study. Ortadoğu Tıp Dergisi 10:3, pages 361-367.
Crossref
Anne-Claire Toffart, Michaël Duruisseaux, Pierre-Yves Brichon, Augustin Pirvu, Julie Villa, Laurent Selek, Pascale Guillem, Isabelle Dumas, Léonie Ferrer, Matteo Giaj Levra & Denis Moro-Sibilot. (2018) Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous Metastasis. The Annals of Thoracic Surgery 105:3, pages 957-965.
Crossref
Christopher M. Jones, Alessandro Brunelli, Matthew E. Callister & Kevin N. Franks. (2018) Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?. Current Surgery Reports 6:2.
Crossref
David E. Gerber. (2018) Oligometastatic Non–Small-Cell Lung Cancer: How Should We Define and Manage It?. Journal of Oncology Practice 14:1, pages 32-34.
Crossref
Kaitai Liu, Dawei Zheng, GuoDong Xu, Zhennan Du & Shibo Wu. (2017) Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis. PLOS ONE 12:11, pages e0187350.
Crossref
T. Walles. (2017) Lokalablative Therapie beim oligometastasierten nicht-kleinzelligen BronchialkarzinomLocal ablative therapy of oligometastatic non-small-cell lung cancer. Der Pneumologe 14:6, pages 371-373.
Crossref
Daniel Buergy & Frederik Wenz. (2017) Der Nutzen einer konsolidierenden Lokaltherapie beim Lungenkarzinom. InFo Onkologie 20:6, pages 24-25.
Crossref
Derek P. Bergsma, Joseph K. Salama, Deepinder P. Singh, Steven J. Chmura & Michael T. Milano. (2017) Radiotherapy for Oligometastatic Lung Cancer. Frontiers in Oncology 7.
Crossref
G. Dupic, J. Biau, A. Bellière-Calandry & M. Lapeyre. (2017) Radiothérapie stéréotaxique hypofractionnée des métastases surrénaliennes. Cancer/Radiothérapie 21:5, pages 404-410.
Crossref
Jingze Zhang, Li Kong, Qinghua Jiao, Minghuan Li & Jingming Yu. (2017) Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead. Cancer Letters 401, pages 46-52.
Crossref
Matteo Brighenti, Fausto Petrelli, Sandro Barni, Barbara Conti, Enrico Sarti, Margherita Ratti, Stefano Panni, Rodolfo Passalacqua & Melissa Bersanelli. (2017) Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?. European Journal of Cancer 79, pages 149-151.
Crossref
Suchit H. Patel, Andreas Rimner, Amanda Foster, Zhigang Zhang, Kaitlin M. Woo, Helena A. Yu, Gregory J. Riely & Abraham J. Wu. (2017) Patterns of initial and intracranial failure in metastatic EGFR-mutant non-small cell lung cancer treated with erlotinib. Lung Cancer 108, pages 109-114.
Crossref
L. Basler, S.G.C. Kroeze & M. Guckenberger. (2017) SBRT for oligoprogressive oncogene addicted NSCLC. Lung Cancer 106, pages 50-57.
Crossref
Daniel Buergy & Frederik Wenz. (2017) Konsolidierende Lokaltherapie beim oligometastasierten NSCLC ohne Progress nach Erstlinien-ChemotherapieConsolidative local therapy in oligometastatic NSCLC without progression after first-line chemotherapy. Strahlentherapie und Onkologie 193:4, pages 341-343.
Crossref
Neil B Desai, Aaron M Laine & Robert D Timmerman. (2017) Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer. The British Journal of Radiology 90:1070, pages 20160500.
Crossref
Chul Kim, Chuong D. Hoang, Aparna H. Kesarwala, David S. Schrump, Udayan Guha & Arun Rajan. (2017) Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer. Journal of Thoracic Oncology 12:2, pages 179-193.
Crossref
Patrick Kelly, Zhe Ma, Said Baidas, Rebecca Moroose, Nikita Shah, Roi Dagan, Eleftherios Mamounas & Justin Rineer. (2017) Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy. International Journal of Breast Cancer 2017, pages 1-7.
Crossref
Jordan A. Torok, Lin Gu, Daniel J. Tandberg, Xiaofei Wang, David H. HarpoleJr.Jr., Chris R. Kelsey & Joseph K. Salama. (2017) Patterns of Distant Metastases After Surgical Management of Non–Small-cell Lung Cancer. Clinical Lung Cancer 18:1, pages e57-e70.
Crossref
Pranshu Bansal, Chad Rusthoven, Yanis Boumber & Gregory N Gan. (2016) The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope. Future Oncology 12:23, pages 2713-2727.
Crossref
Daniel R Gomez, George R BlumenscheinJrJr, J Jack Lee, Mike Hernandez, Rong Ye, D Ross Camidge, Robert C Doebele, Ferdinandos Skoulidis, Laurie E Gaspar, Don L Gibbons, Jose A Karam, Brian D Kavanagh, Chad Tang, Ritsuko Komaki, Alexander V Louie, David A Palma, Anne S Tsao, Boris Sepesi, William N William, Jianjun Zhang, Qiuling Shi, Xin Shelley Wang, Stephen G Swisher & John V Heymach. (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. The Lancet Oncology 17:12, pages 1672-1682.
Crossref
Eduardo Guerrero & Merina Ahmed. (2016) The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer. Lung Cancer 92, pages 22-28.
Crossref
Hani Al-Halabi, Karl Sayegh, Subba R. Digamurthy, Andrzej Niemierko, Zofia Piotrowska, Henning Willers & Lecia V. Sequist. (2015) Pattern of Failure Analysis in Metastatic EGFR-Mutant Lung Cancer Treated with Tyrosine Kinase Inhibitors to Identify Candidates for Consolidation Stereotactic Body Radiation Therapy. Journal of Thoracic Oncology 10:11, pages 1601-1607.
Crossref
Chad G. Rusthoven, Norman Yeh & Laurie E. Gaspar. (2015) Radiation Therapy for Oligometastatic Non–Small Cell Lung Cancer. The Cancer Journal 21:5, pages 404-412.
Crossref
Matthias Guckenberger. (2015) Kombination zielgerichteter Systemtherapie und zielgerichteter Radiotherapie. Info Onkologie 18:5, pages 36-38.
Crossref
Kenneth D. Westover, Puneeth Iyengar, Akanksha Neeraj Sharma & Robert Timmerman. (2015) SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer. Lung Cancer 89:2, pages 87-93.
Crossref
Michael S. Binkley, Nicholas Trakul, Lisa Rose Jacobs, Rie von Eyben, Quynh-Thu Le, Peter G. Maxim, Billy W. LooJr.Jr., David Benjamin Shultz & Maximilian Diehn. (2015) Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 92:5, pages 1044-1052.
Crossref
C. Leduc, D. Antoni, É. Quoix & G. Noël. (2015) Radiothérapie exclusive curative chez un patient atteint d’un carcinome bronchique non à petites cellules de stade IV oligométastatique : cas clinique et revue de la littérature. Cancer/Radiothérapie 19:3, pages 192-197.
Crossref
Matthias Guckenberger. (2015) OligoprogressionOligoprogression. Strahlentherapie und Onkologie 191:5, pages 453-455.
Crossref
Puneeth IyengarBrian D. KavanaghZabi WardakIrma SmithChul AhnDavid E. GerberJonathan DowellRandall HughesRamzi AbdulrahmanD. Ross CamidgeLaurie E. GasparRobert C. DoebelePaul A. BunnHak ChoyRobert Timmerman. (2014) Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non–Small-Cell Lung Cancer. Journal of Clinical Oncology 32:34, pages 3824-3830.
Crossref
F. Sterzing, W. Eberhardt, G. Friedel, C. Pöttgen & S. Rieken. (2014) Oligometastasiertes LungenkarzinomOligometastatic lung cancer. Der Onkologe 20:10, pages 991-997.
Crossref
Joseph K. SalamaMichael T. Milano. (2014) Radical Irradiation of Extracranial Oligometastases. Journal of Clinical Oncology 32:26, pages 2902-2912.
Crossref
Robert D. TimmermanJoseph HermanL. Chinsoo Cho. (2014) Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical Practice. Journal of Clinical Oncology 32:26, pages 2847-2854.
Crossref
Allison B. Ashworth, Suresh Senan, David A. Palma, Marc Riquet, Yong Chan Ahn, Umberto Ricardi, Maria T. Congedo, Daniel R. Gomez, Gavin M. Wright, Giulio Melloni, Michael T. Milano, Claudio V. Sole, Tommaso M. De Pas, Dennis L. Carter, Andrew J. Warner & George B. Rodrigues. (2014) An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer. Clinical Lung Cancer 15:5, pages 346-355.
Crossref
Ravi B. Parikh, Angel M. Cronin, David E. Kozono, Geoffrey R. Oxnard, Raymond H. Mak, David M. Jackman, Peter C. Lo, Elizabeth H. Baldini, Bruce E. Johnson & Aileen B. Chen. (2014) Definitive Primary Therapy in Patients Presenting With Oligometastatic Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 89:4, pages 880-887.
Crossref
Johnny Kao, Chien-Ting Chen, Charles C. L. Tong, Stuart H. Packer, Myron Schwartz, Shu-hsia Chen & Max W. Sung. (2013) Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases. Targeted Oncology 9:2, pages 145-153.
Crossref
Aaron M. Laine, Kenneth D. Westover & Hak Choy. (2014) Radiation Therapy as a Backbone of Treatment of Locally Advanced Non-Small Cell Lung Cancer. Seminars in Oncology 41:1, pages 57-68.
Crossref
Chad G RusthovenTracey E Schefter. (2014) Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastases. Hepatic Oncology 1:1, pages 81-94.
Crossref
Allison Ashworth, David Palma & George Rodrigues. 2014. Brain Metastases from Primary Tumors. Brain Metastases from Primary Tumors 181 196 .
M. Fernández-Velilla Peña, C. Rubio Rodríguez, M. Allona Krauel, O. Hernando Requejo, E. Sánchez Saugar, A. Muro de la Fuente & M.I. Torres Sánchez. (2013) Treatment of lung lesions by stereotactic body radiation therapy after computed tomography guided placement of a Visicoil® marker: Initial experience. Radiología (English Edition) 55:3, pages 225-232.
Crossref
M. Fernández-Velilla Peña, C. Rubio Rodríguez, M. Allona Krauel, O. Hernando Requejo, E. Sánchez Saugar, A. Muro de la Fuente & M.I. Torres Sánchez. (2013) Tratamiento de lesiones pulmonares mediante radioterapia estereotáxica extracraneal tras colocación guiada por tomografía computarizada de marcador Visicoil®: experiencia inicial. Radiología 55:3, pages 225-232.
Crossref
Joseph K. SalamaEverett E. Vokes. (2013) New Radiotherapy and Chemoradiotherapy Approaches for Non–Small-Cell Lung Cancer. Journal of Clinical Oncology 31:8, pages 1029-1038.
Crossref
Joseph K. Salama, John P. Kirkpatrick & Fang-Fang Yin. (2012) Stereotactic body radiotherapy treatment of extracranial metastases. Nature Reviews Clinical Oncology 9:11, pages 654-665.
Crossref
Michael T. Milano, Alan W. Katz, Hong Zhang & Paul Okunieff. (2012) Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study. International Journal of Radiation Oncology*Biology*Physics 83:3, pages 878-886.
Crossref
Andrew Song, Kevin Shiue, Mitchell Machtay, Min Yao, Rodney J Ellis, Zhibin Huang, Nina A Mayr, Bin S Teh & Simon S Lo. (2012) Stereotactic body radiation therapy for metastasis in the lung: an undervalued treatment option with future prospects. Lung Cancer Management 1:1, pages 73-79.
Crossref
Joseph K. Salama, Michael D. Hasselle, Steven J. Chmura, Renuka Malik, Neil Mehta, Kamil M. Yenice, Victoria M. Villaflor, Walter M. Stadler, Philip C. Hoffman, Ezra E. W. Cohen, Philip P. Connell, Daniel J. Haraf, Everett E. Vokes, Samuel Hellman & Ralph R. Weichselbaum. (2011) Stereotactic body radiotherapy for multisite extracranial oligometastases. Cancer 118:11, pages 2962-2970.
Crossref
Michael D. Hasselle, Daniel J. Haraf, Kyle E. Rusthoven, Daniel W. Golden, Ravi Salgia, Victoria M. Villaflor, Niket Shah, Philip C. Hoffman, Steven J. Chmura, Philip P. Connell, Everett E. Vokes, Ralph R. Weichselbaum & Joseph K. Salama. (2012) Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer. Journal of Thoracic Oncology 7:2, pages 376-381.
Crossref
Pretesh R. Patel, David S. Yoo, Yuzuru Niibe, James J. Urbanic & Joseph K. Salama. (2012) A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer. Pulmonary Medicine 2012, pages 1-7.
Crossref
Neha Amin, Tracey E. Schefter, Paul Okunieff, Brian Kavanagh & Michael T. Milano. 2012. Stereotactic Body Radiation Therapy. Stereotactic Body Radiation Therapy 285 303 .
Praveena Cheruvu, Su K Metcalfe, Justin Metcalfe, Yuhchyau Chen, Paul Okunieff & Michael T Milano. (2011) Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer. Radiation Oncology 6:1.
Crossref
Simon S. Lo, Susan D. Moffatt-Bruce, Laura A. Dawson, Roderich E. Schwarz, Bin S. Teh, Nina A. Mayr, Jiade J. Lu, John C. Grecula, Thomas E. Olencki & Robert D. Timmerman. (2011) The role of local therapy in the management of lung and liver oligometastases. Nature Reviews Clinical Oncology 8:7, pages 405-416.
Crossref
Max Dahele & Suresh Senan. (2011) The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms. Cancer Research and Treatment 43:2, pages 75-82.
Crossref
Michael T. Milano & Joseph K. Salama. 2012. Stereotactic Body Radiation Therapy. Stereotactic Body Radiation Therapy 331 343 .
Stanley H. Benedict, Kamil M. Yenice, David Followill, James M. Galvin, William Hinson, Brian Kavanagh, Paul Keall, Michael Lovelock, Sanford Meeks, Lech Papiez, Thomas Purdie, Ramaswamy Sadagopan, Michael C. Schell, Bill Salter, David J. Schlesinger, Almon S. Shiu, Timothy Solberg, Danny Y. Song, Volker Stieber, Robert Timmerman, Wolfgang A. Tomé, Dirk Verellen, Lu Wang & Fang-Fang Yin. (2010) Stereotactic body radiation therapy: The report of AAPM Task Group 101. Medical Physics 37:8, pages 4078-4101.
Crossref
Lawrence B. Marks, Mert Saynak & John P. Christodouleas. (2010) Stage III vs. stage IV lung cancer: “Crossing a Great Divide”. Lung Cancer 67:1, pages 1-3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.